Sponsor pipeline

UNICANCER clinical trial pipeline

Get alerts when UNICANCER's trials change

89 active trials 37 recruiting 29 Phase 3 21 disease areas 9 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

4 trials changed in the last 30 days: 1 stopped, 2 with notable changes, 1 with a minor change only.

  1. Stopped

    Trial terminated

    Sponsor's reason: The study was terminated prematurely due to insufficient patient recruitment.

    Also in this update: Final enrollment: 31 participants — 7% of the 472 planned; Primary completion date changed from estimate of Sep 1, 2026 to Dec 1, 2025

    UNICANCERNot applicable NCT06505018 Registry history

    Updated

Show 1 trial with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
38
Phase 2/3
2
Phase 3
27
Not charted: 22 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 89

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04747054 Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed… Squamous Cell Carcinoma of Head and Neck Recruiting 2026-07-31
NCT06625970 Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated… High Risk Prostate Carcinoma Recruiting 2026-07-31
NCT07106632 Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent… Early Breast Cancer Recruiting 2026-07-31
NCT06606730 Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early… Breast Cancers Recruiting 2026-07-23
NCT07237256 Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated… Breast Cancer Recruiting 2026-05-26
NCT05615818 Personalized Medicine for Advanced Biliary Cancer Patients Biliary Tract Neoplasms Recruiting 2026-05-19
NCT04916613 ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable… Prostate Cancer Metastatic Recruiting 2026-04-28
NCT06276465 Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration… Prostatic Cancer, Castration-Resistant Recruiting 2024-12-20
NCT06496581 Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response… Prostate Cancer Metastatic Recruiting 2024-12-20
NCT07745296 Investigating Precision Medicine in the Adjuvant Setting in Biliary Tract Cancer Biliary Tract Cancer (BTC) Not Yet Recruiting 2026-08-04
NCT01805271 Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of… Primary Non-metastatic Breast Cancer Active, Not Recruiting 2026-07-31
NCT07118800 Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old Locally Advanced Rectal Adenocarcinoma Not Yet Recruiting 2026-07-24
NCT04158362 Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in… Cancer Metastatic Active, Not Recruiting 2026-07-22
NCT07340567 Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal… Colorectal Cancer Active, Not Recruiting 2026-07-22
NCT05552001 Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients… Triple Negative Breast Cancer Active, Not Recruiting 2026-07-21
NCT07717450 Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic… Metastatic Invasive Breast Cancer Not Yet Recruiting 2026-07-21
NCT05078047 Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3… Lung Cancer Metastatic Active, Not Recruiting 2026-07-17
NCT07284394 Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in… Colorectal Adenocarcinoma Metastatic in the Liver Not Yet Recruiting 2026-05-26
NCT01376752 Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment Ovarian Epithelial Cancer Recurrent Active, Not Recruiting 2026-05-20
NCT03774732 PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in… Non Small Cell Lung Cancer Active, Not Recruiting 2026-02-25
NCT01952223 A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and… Adenocarcinoma of Prostate Active, Not Recruiting 2025-07-30
NCT04181203 Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After… Prostate Cancer Active, Not Recruiting 2025-07-30
NCT04115007 Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in… Oligometastatic Hormone Sensitive Prostate Cancer Active, Not Recruiting 2025-06-26
NCT00470223 Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma Sarcoma Active, Not Recruiting 2025-06-08
NCT03799835 Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle… Bladder Cancer Active, Not Recruiting 2024-12-11
See all 89 active UNICANCER trials with filters →

Disease areas by active trials, top 10 of 21

Breast Cancer (31) · Prostate Cancer (10) · Colorectal Cancer (9) · Lung Cancer (9) · Triple-Negative Breast Cancer (7) · Head & Neck Cancer (6) · Bladder Cancer (5) · Sarcoma (5) · Cholangiocarcinoma (4) · Esophageal Cancer (4)

Get alerts when UNICANCER's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free